In a letter to its shareholders, Creative Edge Nutrition Inc (OTCMKTS:FITX) stated that it will re-file the license application under MMPR program for judicial review. The company issued the letter so that it can make shareholders aware with the latest development of license application process. The management informed that the rejection of the application doesn’t means that the company will no longer try for license. The denial is just a procedural issue and it intends to solve it in the coming period.

The unit

Creative Edge created CEN Biotech with a specific purpose in 2013. It is a partially owned subsidiary of the company. The company wanted to spread the use of effective Pharma-grade medical cannabis, and therefore it formulated the specialized unit. However, it failed to get the approval for license application under the MMPR program. It submitted an application to convert into a LP of dried marijuana for medicinal use.

The update

Creative Edge is leaving no stone unturned to boost the confidence in shareholders. It has been issuing a series of letter regarding the license application. It even released another letter in which the company highlighted the Canadian Newspaper, The Globe and Mail. It alleged the newspaper for spreading misrepresented news about the company. The newspaper has been in news for attacking the company in last one year.

The allegations

Creative Edge Nutrition Inc (OTCMKTS:FITX) mentioned in the letter that the newspaper reporter Grant Robertson, working with The Globe and Mail is accountable to run the campaign of untruths and image distortion against the company. The reporter made several false accusations without even making necessary investigations. On Friday’s trading session, the share price of Creative Edge jumped more than 7% to close the trading session at $0.00539. The gains came at a share volume of 33.44 million compared to average volume of 16.43 million.

Previous articleMedical Marijuana Inc (OTCMKTS:MJNA)’s Kannaway Supports CANCERSTOCK
Next articleWhat’s The Buzz Surrounding Ecrypt Technologies Inc (OTCBB:ECRY)?
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg,,, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.